Pharmafile Logo
Pharmafocus logo
Advanced Search

Universal WorldEvents creates dedicated training role

February 14, 2013
Medical Communications, Research and Development, Sales and Marketing Universal WorldEvents

Event management firm Universal WorldEvents has announced the promotion of Sarah Longland to the new role of senior account manager …

Appointment
NICE image

NICE rejects Jakavi

February 13, 2013
Sales and Marketing Jakavi, NICE

NICE has today issued draft guidance saying it does not recommend Novartis’ Jakavi for patients with myelofibrosis, a rare blood …

News
currie_mark_ironwood

Ironwood announces new president of R&D

February 13, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Ironwood

Ironwood Pharmaceuticals has announced the promotion of Mark Currie, to senior vice president, chief scientific officer, and president of research …

Appointment
regeneron image

Sanofi ups stake in Regeneron

February 13, 2013
Sales and Marketing AMD, Regeneron, Sanofi, Zaltrap

Sanofi is increasing its stake in Regeneron Pharmaceuticals by buying shares on the open market and from existing shareholders. The …

News
Shire image

Shire pays Impax $48 million

February 12, 2013
Sales and Marketing ADHD, Adderall, Impax, Shire

Shire has paid $48 million to settle a long-running legal spat with Impax Laboratories over Shire’s supply of an authorised …

News
Perrigo image

Perrigo buys Rosemont for £180 million

February 12, 2013
Manufacturing and Production Perrigo, Rosemont

UK-based Rosemont Pharmaceuticals has been sold by its private equity owner to Perrigo of the US in a £180 million …

News
rajiv_malik

Mylan appoints two heads to Board of directors

February 12, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Mylan

Mylan has announced the appointment of Melina Higgins, a former partner at Goldman Sachs, and Rajiv Malik, currently Mylan’s president, …

Appointment
Novo Nordisk image

FDA rejects Novo diabetes drugs

February 12, 2013
Sales and Marketing FDA, Novo Nordisk, Ryzodeg, Tresiba

The FDA has knocked back two of Novo Nordisk’s diabetes drugs – just weeks after they were approved for use …

News
Merck image

Merck planning more manufacturing cutbacks?

February 11, 2013
Manufacturing and Production Merck, restructuring

Merck & Co has said it intends to make additional reductions to its manufacturing network, although the pace of restructuring …

News
FDA image

FDA offers Alzheimer’s guidance

February 11, 2013
Research and Development, Sales and Marketing Alzheimer's, FDA, Roche, lilly

The FDA has issued guidance to help companies developing new treatments for patients with early-stage Alzheimer’s disease. The US regulator’s …

News
teva image

Teva plans sale of troubled Irvine plant

February 11, 2013
Manufacturing and Production FDA, Teva

Teva has decided to sell off an injectable pharmaceutical production plant in Irvine, California, that was shut down temporarily for …

News
screen_shot_2013-02-11_at_11

Teva appoints Arie Belldegrun to Board of directors

February 11, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Arie Belldegrun, Teva

Teva Pharmaceuticals has announced that Dr Arie Belldegrun has been appointed by the directors of Teva to fill a vacancy …

Appointment

£20m research boost for Scottish biotech

February 11, 2013
Research and Development, Sales and Marketing Bayer, BioCity Scotland, Dundee, EFPIA

BioCity Scotland and the University of Dundee are to play key roles in a newly-launched pan-European drug discovery project. In …

News
novartis image

Novartis’ Nebraska OTC plant still troubles company

February 11, 2013
Manufacturing and Production Novartis, OTC

Novartis has been forced to recall various over-the-counter (OTC) medicines made at its plant in Lincoln, Nebraska, after discovering failures …

News

Contract research news in brief

February 11, 2013
Research and Development Antabio, Aptuit, Argenta, Cross Country Healthcare, ICON, PPD, Quintiles, Verum.de

Icon offers $52m for CCH’s clinical services division, plus updates from PPD, Aptuit, Argenta, Quintiles and Verum.de.

News

Pharma manufacturing news in brief

February 11, 2013
Manufacturing and Production Almac, MeadWestvaco, Rexam, UPS, lilly

A round-up of pharma manufacturing news, including facility updates from MeadWestvaco, Rexam, Almac, UPS and Kemwell Biopharma. MeadWestvaco has said …

News

Sanofi won’t follow trend for spin-offs

February 8, 2013
Sales and Marketing Abbott, Pfizer, Sanofi, Viehbacher

Sanofi’s chief executive Chris Viehbacher says the firm plans to maintain its portfolio of business divisions for the foreseeable future, …

News
GSK image

‘Challenging’ Europe slows GSK

February 8, 2013
Sales and Marketing GSK, austerity, restructuring

‘Challenging’ economic conditions in Europe are among the factors GlaxoSmithKline is blaming for its sluggish performance, with turnover worldwide down …

News
lilly image

Lilly abandons RA drug

February 8, 2013
Research and Development, Sales and Marketing RA, lilly, tabalumab

Lilly is abandoning its late-stage trial into investigational rheumatoid arthritis (RA) drug tabalumab but insists the move has nothing to …

News

Lexapro US loss hits Lundbeck

February 7, 2013
Sales and Marketing Danish, Lexapro, Lundbeck

The loss of US patent protection on antidepressant Lexapro has put a significant dent in Lundbeck’s financial performance for 2012. …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about the menopause

March 6, 2026

Zello Appoints Kevin Bailey as Group Chief Medical Officer

March 6, 2026

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026